Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.68 USD | -2.15% | -2.79% | -46.16% |
Apr. 02 | QuidelOrtho Shares Fall on Decision to Withdraw FDA 510(k) Submission for Savanna RVP4+ Assay | MT |
Apr. 02 | QuidelOrtho Gets US FDA Clearance For QuickVue COVID-19 Test | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-46.16% | 2.71B | |
-15.28% | 18.56B | |
+17.00% | 1.85B | |
-0.51% | 1.66B | |
+25.65% | 1.22B | |
-13.90% | 989M | |
-21.76% | 896M | |
-19.12% | 660M | |
+6.37% | 490M | |
-.--% | 300M |
- Stock Market
- Equities
- QDEL Stock
- News QuidelOrtho Corporation
- RBC Initiates QuidelOrtho at Outperform With $125 Price Target, Sees Potential for Market Share Gains, Sales Acceleration Beyond 2024